Table 1 Patient characteristics at baseline
From: Mid-term results of 150 TAVI comparing apical versus femoral approaches
Characteristics | All patients (n = 150) | Transfemoral approach (n = 78) | Transapical approach (n = 72) | p |
|---|---|---|---|---|
Male gender | 68 (45.3 %) | 35 (44.9 %) | 33 (45.8 %) | NS |
Age (years) | 82.6 +/− 6.9 | 83.5 +/− 6.7 | 81.7 +/− 7.0 | NS |
BMI | 25.4 +/− 4.1 | 24.9 +/− 4,2 | 24.9 +/− 4.1 | NS |
Coronary artery disease | 70 (46.6 %) | 32 (41.0 %) | 38 (52.8 %) | NS |
PCI | 43 (28.7 %) | 21 (27.0 %) | 22 (30.6 %) | NS |
Previous myocardial infarction | 16 (10.7 %) | 7 (9.0 %) | 9 (12.5 %) | NS |
Previous cardiac surgery | 31 (20.7 %) | 12 (15.4 %) | 19 (26.4 %) | 0.096 |
CABG | 28 (18.7 %) | 10 (12.8 %) | 18 (25.0 %) | 0.056 |
Mitral mechanical prosthesis | 1 (0.7 %) | 0 (0 %) | 1 (1.4 %) | NS |
Aortic bioprosthesis | 2 (1.3 %) | 2 (2.6 %) | 0 (0 %) | NS |
Aortic balloon valvuloplasty | 3 (2 %) | 1 (1.3 %) | 2 (2.8 %) | NS |
Hypertension | 89 (59.3 %) | 47 (60.3 %) | 42 (58.4 %) | NS |
Diabetes | 42 (28 %) | 24 (30.8 %) | 18 (25.0 %) | NS |
Smoking | 46 (30.6 %) | 17 (21.8 %) | 29 (40.3 %) | 0.014 |
Plasma creatinine (μmol/L) | 113.5 +/−115.2 | 113.4+/−127.6 | 114.0 +/−101.2 | NS |
Renal dialysis | 3 (2 %) | 2 (2.6 %) | 1 (1.4 %) | NS |
COPD | 24 (16 %) | 8 (10.3 %) | 16 (22.2 %) | 0.046 |
Peripheral vascular disease | 25 (16.6 %) | 11 (14.1 %) | 14 (19.4 %) | NS |
Cerebrovascular disease | 20 (13.3 %) | 12 (15.4 %) | 8 (11.1 %) | NS |
Euroscore | 21.67 +/− 11.3 | 20.5 +/− 10.4 | 22.9 +/− 12.1 | NS |
STS | 9.65 +/− 5.95 | 8.8 +/− 4.5 | 10.3 +/− 7.0 | NS |
Acute pulmonary edema | 21 (14 %) | 6 (7.7 %) | 15 (20.8 %) | 0.020 |
Heart failure | 39 (26 %) | 15 (19.2 %) | 24 (33.3 %) | 0.049 |
Syncope | 6 (4 %) | 3 (3.8 %) | 3 (41.7 %) | NS |
Angor pectoris | 11 (7.4 %) | 7 (9.0 %) | 4 (5.6 %) | NS |